Trial · NCT06026163
Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory Distress
NCT06026163, Phase 2, Phase 3, Recruiting, Ministry of Health, Saudi Arabia
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory Distress. Trials, record NCT06026163. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06026163
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory Distress
- NCT number
- NCT06026163
- Status
- Recruiting
- Phases
- Phase 2, Phase 3
- Enrollment
- 134 participants, estimated
- Lead sponsor
- Ministry of Health, Saudi Arabia
- Conditions
- Prematurity, Respiratory Disease, Ventilator Lung; Newborn
- Interventions
- Caffeine citrate, Placebo
- First posted
- 2023-09-06
- Last updated
- 2025-06-27
Source ClinicalTrials.gov
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Duration of respiratory support | 28 days | cumulative duration of mechanical ventilation, non-invasive positive pressure ventilation and nasal cannula therapy (days) |
| Secondary | Episodes of apnea | 28 gays | the cessation of breathing for more than 20 seconds or cessation of breathing for accompanied by bradycardia or desaturation |
| Secondary | Failure of extubation | 28 days | need of re-intubation within 72 h of extubation from mechanical ventilation |
| Secondary | Duration of caffeine | 28 days | Days of caffeine treatment |
| Secondary | Length of hospital stay | 28 days | days of hospital admission |
| Secondary | Time to full enteral and oral feeding | 28 days | days to reach full enteral feeds |
| Secondary | Adverse effects of caffeine use | 28 days | Tachycardia, irritability, feeding intolerance, hypertension |
| Secondary | Caffeine withhold | 28 days | Caffeine withhold for suspected side effects |
| Secondary | Weight gain per day | 28 days | Weight gain per day (gram) |
| Secondary | Mortality | 28 days | Death before hospital discharge |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06026163
GET https://conductscience.org/api/trials/v1/NCT06026163/registered